Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster

dc.contributorApplied Biology
dc.contributorUniversity Hospital Center “Sestre milosrdnice”
dc.contributorUniversidade de São Paulo (USP)
dc.contributorAlpert Medical School of Brown University
dc.contributorDermatology Department
dc.contributorUniversity of Miami
dc.contributorNew York University School of Medicine
dc.contributorUniversity of Claifornia
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversity of Melbourne
dc.contributorFederal University of the State of Rio de Janeiro and Policlinica Geral do Rio de Janeiro
dc.contributorBulovka Hospital
dc.date.accessioned2021-06-25T10:47:15Z
dc.date.accessioned2022-12-19T22:23:45Z
dc.date.available2021-06-25T10:47:15Z
dc.date.available2022-12-19T22:23:45Z
dc.date.created2021-06-25T10:47:15Z
dc.date.issued2021-01-01
dc.identifierMedical Hypotheses, v. 146.
dc.identifier1532-2777
dc.identifier0306-9877
dc.identifierhttp://hdl.handle.net/11449/206991
dc.identifier10.1016/j.mehy.2020.110439
dc.identifier2-s2.0-85097791083
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5387588
dc.languageeng
dc.relationMedical Hypotheses
dc.sourceScopus
dc.subjectAndrogen receptor
dc.subjectAndrogenetic alopecia
dc.subjectCOVID-19
dc.subjectGabrin sign
dc.subjectSARS-CoV-2
dc.subjectVaccine
dc.titleAndrogenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución